Pharma Journalist 8769 posts 0 comments

January 27-29, 2026 | Boston, MA – With the exciting news of Novartis acquiring Avidity Biosciences, SanegeneBio and Eli Lilly's partnership worth $1.2B to develop RNAi therapeutics for…
Read More...

Ionis Pharmaceuticals has received a significant boost in its neurology pipeline with the U.S. Food and Drug Administration granting Breakthrough Therapy designation to zilganersen, the…
Read More...

Eli Lilly and Company has announced that the U.S. Food and Drug Administration (FDA) has granted expanded approval for Jaypirca (pirtobrutinib) for adults with relapsed or refractory…
Read More...

Taiwan-based Formosa Pharmaceuticals (6838.TW) has entered into an exclusive licensing agreement with Singapore-headquartered Rxilient Medical Pte. Ltd., granting the company…
Read More...

Global biopharmaceutical contract development and manufacturing organization (CDMO) AGC Biologics has announced a major expansion of its Cell Line Development Center of Excellence…
Read More...

The U.S. Food and Drug Administration (FDA) has appointed Tracy Beth Høeg, M.D., Ph.D., as the acting director of the Center for Drug Evaluation and Research (CDER), marking a…
Read More...

The U.S. Food and Drug Administration (FDA) has issued new draft guidance identifying specific drug product types for which six-month non-human primate (NHP) toxicity studies can be…
Read More...

Citizen Health has announced a major strategic partnership with UCB, a global biopharmaceutical leader in neurological and autoimmune research, to accelerate drug discovery and…
Read More...

IQVIA has announced a major strategic collaboration with Amazon Web Services (AWS), naming the cloud company as its Preferred Agentic Cloud Provider—a move set to accelerate the digital…
Read More...

Ionis Pharmaceuticals has announced a major regulatory milestone for its investigational therapy olezarsen, as the U.S. Food and Drug Administration (FDA) has granted it Breakthrough…
Read More...